These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Donor selection for allogenic bone marrow transplantation from 1991 to 1995. (The Prague Center for Bone Marrow Transplantation)]. Korínková P; Matĕjková E; Vítek A Cas Lek Cesk; 1996 Jun; 135(12):389-92. PubMed ID: 8706078 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used. Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: which to choose? Elfenbein GJ Pediatr Transplant; 2005 Dec; 9 Suppl 7():37-47. PubMed ID: 16305616 [TBL] [Abstract][Full Text] [Related]
5. [Umbilical cord blood as a source of stem cells]. Bojanić I; Golubić Cepulić B Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834 [TBL] [Abstract][Full Text] [Related]
6. The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications. de Vries EG; Vellenga E; Kluin-Nelemans JC; Mulder NH Eur J Cancer; 2004 Sep; 40(13):1987-92. PubMed ID: 15315808 [TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue. Dickhut A; Schwerdtfeger R; Kuklick L; Ritter M; Thiede C; Neubauer A; Brendel C Ann Hematol; 2005 Oct; 84(11):722-7. PubMed ID: 16132912 [TBL] [Abstract][Full Text] [Related]
9. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
10. Risk assessment in haematopoietic stem cell transplantation: stem cell source. Urbano-Ispizua A Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961 [TBL] [Abstract][Full Text] [Related]
11. [What is a non-myeloablative transplantation of hematopoietic cells?]. Mayer J Vnitr Lek; 2001 Sep; 47 Suppl 1():29-33. PubMed ID: 11693059 [TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation. Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood progenitor cell or bone marrow transplantation: controversy remains. Koca E; Champlin RE Curr Opin Oncol; 2008 Mar; 20(2):220-6. PubMed ID: 18300773 [TBL] [Abstract][Full Text] [Related]
14. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor. Tanaka T; Ishida H; Shirakawa H; Amano H; Nishida H; Tanabe K Int J Urol; 2007 Nov; 14(11):1044-5. PubMed ID: 17956534 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431 [TBL] [Abstract][Full Text] [Related]
17. [Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation]. Kuroki F; Goto H; Yanagimachi M; Kajiwara R; Fujii H; Isaki S; Takahashi H; Ikuta K; Yokota S Rinsho Ketsueki; 2006 Jul; 47(7):639-44. PubMed ID: 16910574 [TBL] [Abstract][Full Text] [Related]
18. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration. Smiler D; Soltan M; Albitar M Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524 [TBL] [Abstract][Full Text] [Related]
19. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study on autologous implantation between bone marrow stem cells and peripheral blood stem cells for treatment of lower limb ischemia]. Gu Y; Zhang J; Qi L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jul; 21(7):675-8. PubMed ID: 17694651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]